esv3860455
- Organism: Homo sapiens
- Study:estd219 (1000 Genomes Consortium Phase 3 Integrated SV)
- Variant Type:inversion
- Method Type:Sequencing
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: No
- Region Size:20,229
- Publication(s):1000 Genomes Consortium Phase 3 Integrated SV
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 250 SVs from 41 studies. See in: genome view
Overlapping variant regions from other studies: 245 SVs from 41 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop |
---|---|---|---|---|---|---|---|---|---|
esv3860455 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000010.11 | Chr10 | 48,251,769 (-193, +193) | 48,271,997 (-193, +193) |
esv3860455 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000010.10 | Chr10 | 49,459,812 (-193, +193) | 49,480,040 (-193, +193) |
Variant Call Information
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop |
---|---|---|---|---|---|---|---|---|---|
essv21965499 | Remapped | Perfect | NC_000010.11:g.(48 251576_48251962)_( 48271804_48272190) inv | GRCh38.p12 | First Pass | NC_000010.11 | Chr10 | 48,251,769 (-193, +193) | 48,271,997 (-193, +193) |
essv21965499 | Submitted genomic | NC_000010.10:g.(49 459619_49460005)_( 49479847_49480233) inv | GRCh37 (hg19) | NC_000010.10 | Chr10 | 49,459,812 (-193, +193) | 49,480,040 (-193, +193) |